Nutropin AQ

This page contains recent news articles, when available, and an overview of Nutropin AQ but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Tercica Announces Agreement with Genentech for Worldwide Growth …  -  Jul 10, 2007
Nutropin AQ[R] is supplied as 10 mg of sterile liquid somatropin per ... Nutropin AQ[R] is approved for the treatment of GHD in children and adults, ... Free with registration - Business Wire - AccessMyLibrary.com

Article: Resins.(New Products)(Buyers Guide) - JCT CoatingsTech | …  -  Jun 1, 2005
Article: FDA APPROVES NUTROPIN AQ PEN FOR DELIVERY OF GROWTH ... ... South San Francisco, has announced that the Nutropin AQ Pen(TM) has received clearance ... Pay-Per-View - JCT CoatingsTech - HighBeam Research

Genentech and Ipsen Agree to Develop Sustained-Release Formulations …  -  Mar 21, 2005
Nutropin AQ Pen(R) for use with the Nutropin AQ Pen(R) cartridge was cleared for ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... RedOrbit

Tercica, Genentech Announce Agreement for Nurtopin AQ and Increlex  -  Jul 13, 2007
Nutropin AQ (somatropin (rDNA origin)) and Increlex (mecasermin (rDNA origin) injection) were originally designed and formulated to be combined and ... FDA news - FDA news (subscription)

Merger and Acquisition Scenario  -  Aug 19, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Tercica Reports Fourth Quarter and Year-End 2007 Financial Results  -  Feb 27, 2008
The goal of the study is to provide a majority of patients with a co-mixture of Nutropin AQ® and Increlex® administered as single injection. ... Lifescience-online

Collaborations; Companies to develop sustained-release formulations...  -  Apr 18, 2005
Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Collaborations; Companies to develop sustained-release formulations...  -  Apr 22, 2005
Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - Genomics & Genetics Weekly - Factiva, from Dow Jones

Company Profile Report  -  Oct 11, 2008
Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Pituitary Gland Disorders. Acromegaly. Somatostatin Analogs ... $50.00 - Revere Reports - Revere

Collaborations; Companies to develop sustained-release formulations...  -  Apr 19, 2005
Nutropin AQ Pen for use with the Nutropin AQ Pen cartridge was cleared for marketing ... Nutropin AQ is supplied as 10 mg of sterile liquid somatropin per ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Company Profile Report  -  Oct 11, 2008
Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Pituitary Gland Disorders. Acromegaly. Somatostatin Analogs ... $50.00 - Revere - Alacra Store

StreetInsider.com Pre-Open Movers 07/11  -  Jul 11, 2007
Nutropin AQ and Increlex were originally designed and formulated so that the therapies could be combined and potentially given as a single, daily injection. ... StreetInsider.com - StreetInsider.com (subscription)

Genentech Stretches Nutropin Markets With New Approvals  -  Jul 8, 2005
The company s growth hormone franchise also includes Nutropin AQ Pen for use with the Nutropin AQ Pen Cartridge. Previously, a long-acting version also was ... BioWorld Online - BioWorld Online

Competitors by Product Report  -  Oct 11, 2008
Products:. Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Abbott Laboratories (ABT) Products: ... $75.00 - Revere - Alacra Store

Merger and Acquisition Scenario  -  Apr 15, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Global deals network.  -  Aug 1, 2007
...for the development, manufacture, and commercialization of two products containing Genentech's recombinant human growth hormone Nutropin AQ (somatropin, ... Free with registration - Biopharm International - AccessMyLibrary.com

Competitors by Product Report  -  Oct 11, 2008
Products:. Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Abbott Laboratories (ABT) Products: ... $75.00 - Revere Reports - Revere

FDA Safety Labeling Changes: Activella, Duramorph PF, Nutropin  -  Sep 7, 2005
Nutropin and Nutropin AQ injections are indicated for the long-term treatment of growth failure due to a lack of adequate endogenous GH secretion, ... Medscape

Merger and Acquisition Scenario  -  May 13, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Tercica Initiates Phase II Clinical Trial with Next-Generation Growth...  -  Jan 22, 2008
...two products containing Genentech's recombinant human growth hormone Nutropin AQ(R) and Tercica's recombinant insulin-like growth factor-1 Increlex(R). ... Genetic Engineering News - Genetic Engineering News (press release)

Merger and Acquisition Scenario  -  Mar 11, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Nutropin Depot encapsulated sustained-release growth hormone, Nutropin growth hormone, Protropin growth hormone, Nutropin AQ and Nutropin AQ Pen liquid ... $250.00 - Revere Reports - Revere

Drug/Medical Device Report Tercica, Inc. (TRCA)  -  Oct 11, 2008
Genentech, Inc. (DNA) / Nutropin/Nutropin AQ. (Recombinant Somatropin (Human Growth ... Origin)/Nutropin AQ (Somatropin rDNA. Origin) Combination Products ... $70.00 - Revere Reports - Revere

Genentech stretches nutropin markets.(Friday, July 8)(Genentech...  -  Jul 11, 2005
...as the FDA approved Nutropin (somatropin [rDNA origin] for injection) and Nutropin AQ (somatropin [rDNA origin] injection) for the long-term treatment ... Pay-Per-View - BioWorld Week - Factiva, from Dow Jones

Stocks to Watch: Genentech, Compuware and Ryland  -  Jul 11, 2007
The two products contain Genentech's recombinant human growth hormone Nutropin AQ and Tercica's recombinant insulin-like growth factor-1 Increlex. ... FOXNews

Wednesday's biggest stock gainers and decliners - MarketWatch  -  Jul 11, 2007
The two products contain Genentech's recombinant human growth hormone Nutropin AQ and Tercica's recombinant insulin-like growth factor-1 Increlex. ... MarketWatch

Genentech's Potter to Serve as Consultant  -  Aug 16, 2005
Potter joined Genentech in 2000 as executive vice president and chief operating officer and oversaw the launch of Avastin, Raptiva, Xolair, Nutropin AQ Pen, ... TheStreet.com - TheStreet.com (subscription)

Ipsen buys Tercica for $404 million  -  Jun 5, 2008
Through a deal last summer, Tercica and Genentech are trying to develop a combination of Increlex and Genentech's Nutropin AQ, the leading recombinant human ... Bizjournals.com

Biotech Tercica rides a wave of new drugs  -  Sep 21, 2007
The companies eventually could sell a combination of Increlex and Genentech's Nutropin AQ -- the leading recombinant human growth hormone sold in the United ... Bizjournals.com

Biomarker group grows  -  Sep 3, 2007
...various indications, using Genentech's Nutropin AQ (recombinant somatropin) and Tercica's Increlex (recombinant insulin-like growth factor 1 (IGF-1)). ... Nature.com

Tercica founder Ross Clark dies  -  Jun 24, 2008
Tercica and Genentech also announced a deal last summer to develop a combination of Increlex and Genentech's recombinant human growth hormone Nutropin AQ ... Bizjournals.com

Ipsen and Tercica to Enter into Worldwide Strategic Collaboration in ...  -  Jul 19, 2006
Ibsen is Genentech's European partner for the Nutropin AQ brand of growth hormone. Third, each company will grant to the other certain joint development and ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Buying drugs online? Be aware of serious risks  -  Feb 5, 2008
Besides Lipitor, counterfeit products included Combivir, Epogen, Gamimune, Neupogen, Nutropin AQ, Serostim, Procrit, Viagra and Zyprexa. ... $2.95 - Lexington Herald Leader - NewsBank

Supporting the Little Company  -  Jul 12, 2007
The partnership involves combining Genentech's human growth hormone Nutropin AQ with Tercica's insulin-like growth factor Increlex for treating patients ... fool.com

Altus Pharmaceuticals Presents Positive Data From Phase I Study of …  -  Sep 28, 2005
...injection of ALTU-238 were comparable to those achieved in subjects receiving the same amount of growth hormone with 7 daily injections of Nutropin AQ. ... RedOrbit

ePt@PharmTech.com.(IN THE FIELD: MONTH IN REVIEW)(briefs)( …  -  Sep 1, 2007
...manufacture, and worldwide commercialization of two products containing Genentech's recombinant human-growth hormone "Nutropin AQ" (somatropin (rDNA ... Free with registration - Pharmaceutical Technology - AccessMyLibrary.com

Are Hopes Getting Too High for Genentech?  -  May 19, 2008
In addition to the oncology drugs, DNA manufactures heart attack treatment- Activase, Nutropin and Nutropin AQ, growth hormone products, and Pulmozyme, ... Schaeffers Research

Genentech: in business for life.(Investor Sheet Fact)  -  Mar 1, 2005
Product development pipeline AS OF JANUARY 10, 2005 AWAITING FDA ACTION NUTROPIN & NUTROPIN AQ IDIOPATHIC SHORT STATURE PHASE III AVASTIN ADJUVANT ... Free with registration - Research - AccessMyLibrary.com

Tercica begins dosing in Ph II IGF-1 deficiency trial.  -  Feb 4, 2008
...product Increlex (mecasemin [rDNA] origin) in combination with Genentech's recombinant human growth hormone Nutropin AQ (somatropin [rDNA] origin). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Loislaw Federal District Court Opinions - ALLEN v. CRYSTALCOAST, INC …  -  May 11, 2007
In order to treat his growth hormone deficiency, in March, 1999, Willie's physicians prescribed a growth hormone called Nutropin AQ ("Nutropin"). ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Breaking News from Open Energy Corporation (OTCBB: OEGY).  -  Jun 20, 2007
...and Nutropin and Nutropin AQ growth hormone products for treating growth hormone deficiency in children and adults, growth failure associated with ... $4.95 - M2 Presswire - ECNext

Medication safety issue brief: counterfeit drug prevention and …  -  Aug 1, 2005
Nutropin AQ 14. Panglobutin 15. Procrit 16. Retrovir 17. Risperdal 18. Rocephin 19. Serostim 20. Sustiva 21. Trizivir 22. Venogtobutin 23. Viagra 24. Videx ... $9.94 - H&HN - Alacra Store

Competitors by Product Report  -  Jun 7, 2008
Tercica, Inc. (TRCA) Products:. Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products ... $75.00 - Revere - Alacra Store

Press Release: Tercica, Inc. to Release First Quarter Financial...  -  Apr 27, 2005
Nutropin AQ[R] and Tercica's recombinant human ... Webcast Information Tercica's senior management ... review first quarter financial results via a ... Pay-Per-View - PR Newswire - HighBeam Research

ePt@PharmTech.com.  -  Sep 1, 2007
...manufacture, and worldwide commercialization of two products containing Genentech's recombinant human-growth hormone "Nutropin AQ" (somatropin (rDNA ... $9.94 - Pharmaceutical Technology - Alacra Store

Press Release: Tercica, Inc. to Release Second Quarter Financial...  -  Jul 20, 2005
Nutropin AQ[R] and Tercica's recombinant human ... Webcast Information Tercica's senior management ... review first quarter financial results via a ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Examine the Changing Dynamics Prevelant in the US …  -  Sep 16, 2008
...recombinant human growth hormone Nutropin AQ (somatropin ... treatment of short stature, adult growth hormone deficiency (AGHD), and potentially ... ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Shareholders alert for Tercica Inc. - M2 Presswire | …  -  Jul 11, 2007
ExplorationInvestor: Tercica Announces Agreement ... for Worldwide Growth Hormone(C)1994 ... recombinant human growth hormone Nutropin AQ ... origin)) and ... Pay-Per-View - M2 Presswire - HighBeam Research

Competitors by Product Report  -  Jun 7, 2008
Tercica, Inc. (TRCA) Products:. Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products ... $75.00 - Revere Reports - Revere

Genentech: in business for life.(Investor fact sheet) | Article from...  -  Sep 1, 2005
NUTROPIN AQ IDIOPATHIC SHORT STATURE PHASE III AVASTIN ADJUVANT COLORECTAL CANCER METASTATIC ... Research. Article: Citigroup depositary receipt issuers. ... Pay-Per-View - Research - HighBeam Research

Tercica and Genentech sign R&D deal.(research and development)(Brief ...  -  Jul 16, 2007
...manufacture and commercialization of two products, namely the human growth hormone Nutropin AQ (somatropin) and the recombinant insulin-like growth ... $4.95 - Pharma Marketletter - ECNext

Competitors by Product Report  -  Jun 21, 2008
Tercica, Inc. (TRCA) Products:. BIM 28131 (Ghrelin Agonist); Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products ... $75.00 - Revere Reports - Revere

Questions & Answers From The Pharmacy / Be cautious when buying …  -  Jan 28, 2008
Besides Lipitor, counterfeited products included Combivir, Epogen, Gamimune, Neupogen, Nutropin AQ, Serostim, Procrit, Viagra and Zyprexa. ... $2.95 - Press of Atlantic City, The - NewsBank

Drug/Medical Device Report Tercica, Inc. (TRCA)  -  Oct 11, 2008
Biopharmaceuticals. Endocrinology/Metabolism. Phase I/Phase II Clinical Stage Products. Increlex (Mecasermin rDNA. Origin)/Nutropin AQ (Somatropin rDNA. $70.00 - Revere - Alacra Store

Growth hormone improves clinical outcomes in cystic fibrosis.(Tips...  -  May 1, 2007
...randomized the participants into a treatment group using daily injections of recombinant human growth hormone (Nutropin AQ) or a no-treatment group. ... $4.95 - American Family Physician - ECNext

Press Release: luTercica Inc Announces Partnership. - M2 Presswire | ...  -  Jul 12, 2007
The drugs will combine Tercica's Increlex and Genentech's human growth hormone Nutropin AQ. Tercica plans to start two mid-stage trials of the combined drug ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Norditropin(R) Approved for Treatment of Children with...  -  Sep 21, 2007
Article: FDA clears Genentech's Nutropin AQ for use in Turner ... Business Wire; April 1, 1997 ; 700+ words ... ... for the long-term treatment of short ... Pay-Per-View - PR Newswire - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy